182 related articles for article (PubMed ID: 16163059)
1. c-Src regulates constitutive and EGF-mediated VEGF expression in pancreatic tumor cells through activation of phosphatidyl inositol-3 kinase and p38 MAPK.
Summy JM; Trevino JG; Baker CH; Gallick GE
Pancreas; 2005 Oct; 31(3):263-74. PubMed ID: 16163059
[TBL] [Abstract][Full Text] [Related]
2. Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis.
Trevino JG; Summy JM; Gray MJ; Nilsson MB; Lesslie DP; Baker CH; Gallick GE
Cancer Res; 2005 Aug; 65(16):7214-22. PubMed ID: 16103072
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.
Trevino JG; Summy JM; Lesslie DP; Parikh NU; Hong DS; Lee FY; Donato NJ; Abbruzzese JL; Baker CH; Gallick GE
Am J Pathol; 2006 Mar; 168(3):962-72. PubMed ID: 16507911
[TBL] [Abstract][Full Text] [Related]
4. AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes.
Summy JM; Trevino JG; Lesslie DP; Baker CH; Shakespeare WC; Wang Y; Sundaramoorthi R; Metcalf CA; Keats JA; Sawyer TK; Gallick GE
Mol Cancer Ther; 2005 Dec; 4(12):1900-11. PubMed ID: 16373705
[TBL] [Abstract][Full Text] [Related]
5. The RON tyrosine kinase receptor regulates vascular endothelial growth factor production in pancreatic cancer cells.
Thomas RM; Jaquish DV; French RP; Lowy AM
Pancreas; 2010 Apr; 39(3):301-7. PubMed ID: 20358644
[TBL] [Abstract][Full Text] [Related]
6. Arginine vasopressin stimulates mesangial cell proliferation by activating the epidermal growth factor receptor.
Ghosh PM; Mikhailova M; Bedolla R; Kreisberg JI
Am J Physiol Renal Physiol; 2001 Jun; 280(6):F972-9. PubMed ID: 11352836
[TBL] [Abstract][Full Text] [Related]
7. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.
Ischenko I; Guba M; Yezhelyev M; Papyan A; Schmid G; Green T; Fennell M; Jauch KW; Bruns CJ
Angiogenesis; 2007; 10(3):167-82. PubMed ID: 17486419
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Anti-Cancer Effects of AKT and SRC Inhibition in Human Pancreatic Cancer Cells.
Ahn K; O YM; Ji YG; Cho HJ; Lee DH
Yonsei Med J; 2018 Aug; 59(6):727-735. PubMed ID: 29978609
[TBL] [Abstract][Full Text] [Related]
9. Pomolic acid suppresses HIF1α/VEGF-mediated angiogenesis by targeting p38-MAPK and mTOR signaling cascades.
Park JH; Yoon J; Park B
Phytomedicine; 2016 Dec; 23(14):1716-1726. PubMed ID: 27912873
[TBL] [Abstract][Full Text] [Related]
10. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts.
Yen ML; Su JL; Chien CL; Tseng KW; Yang CY; Chen WF; Chang CC; Kuo ML
Mol Pharmacol; 2005 Oct; 68(4):1061-73. PubMed ID: 15998873
[TBL] [Abstract][Full Text] [Related]
11. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.
Tang Y; Nakada MT; Rafferty P; Laraio J; McCabe FL; Millar H; Cunningham M; Snyder LA; Bugelski P; Yan L
Mol Cancer Res; 2006 Jun; 4(6):371-7. PubMed ID: 16778084
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia and EGF Stimulation Regulate VEGF Expression in Human Glioblastoma Multiforme (GBM) Cells by Differential Regulation of the PI3K/Rho-GTPase and MAPK Pathways.
Nicolas S; Abdellatef S; Haddad MA; Fakhoury I; El-Sibai M
Cells; 2019 Nov; 8(11):. PubMed ID: 31698752
[TBL] [Abstract][Full Text] [Related]
13. Role of epidermal growth factor and ErbB2 receptors in 3T3-L1 adipogenesis.
Harrington M; Pond-Tor S; Boney CM
Obesity (Silver Spring); 2007 Mar; 15(3):563-71. PubMed ID: 17372305
[TBL] [Abstract][Full Text] [Related]
14. Opposing roles of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in the cellular response to ionizing radiation in human cervical cancer cells.
Kim MJ; Choi SY; Park IC; Hwang SG; Kim C; Choi YH; Kim H; Lee KH; Lee SJ
Mol Cancer Res; 2008 Nov; 6(11):1718-31. PubMed ID: 19010820
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
[TBL] [Abstract][Full Text] [Related]
16. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signaling.
Sun Y; Wu C; Ma J; Yang Y; Man X; Wu H; Li S
Exp Cell Res; 2016 Oct; 347(2):274-82. PubMed ID: 27426724
[TBL] [Abstract][Full Text] [Related]
18. VEGF-A/VEGFR-2 signaling plays an important role for the motility of pancreas cancer cells.
Doi Y; Yashiro M; Yamada N; Amano R; Noda S; Hirakawa K
Ann Surg Oncol; 2012 Aug; 19(8):2733-43. PubMed ID: 22207048
[TBL] [Abstract][Full Text] [Related]
19. p38 and EGF receptor kinase-mediated activation of the phosphatidylinositol 3-kinase/Akt pathway is required for Zn2+-induced cyclooxygenase-2 expression.
Wu W; Silbajoris RA; Whang YE; Graves LM; Bromberg PA; Samet JM
Am J Physiol Lung Cell Mol Physiol; 2005 Nov; 289(5):L883-9. PubMed ID: 15980035
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor-induced matrix metalloproteinase-1 expression is negatively regulated by p38 MAPK in human skin fibroblasts.
Park CH; Chung JH
J Dermatol Sci; 2011 Nov; 64(2):134-41. PubMed ID: 21872446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
